Peter Kamper

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma

Peter Kamper, Knud Bendix, Stephen Hamilton‐Dutoit et al. · Haematologica · 2010 · 196 citations · Full text

Medicine, Oncology, Pathology +17

Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma

Peter Kamper, Maja Ludvigsen, Knud Bendix et al. · Blood · 2011 · 84 citations · Full text

Life Sciences, Immunology, Oncology +17

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study

Claudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi et al. · The Lancet Haematology · 2016 · 74 citations

Medicine, Oncology, Hematologic Oncology +16

Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

Fong Chun Chan, Anja Mottok, Alina S. Gerrie et al. · Journal of Clinical Oncology · 2017 · 57 citations · Full text

Life Sciences, Oncology, Pathology +17

High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Peter Hollander, Peter Kamper, Karin E. Smedby et al. · Blood Advances · 2017 · 50 citations · Full text

Medicine, Hematology, Oncology +16